Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.
Phylogica Limited
ASX:PYC ISIN:AU000000PYC7
新聞
2010年12月20日澳洲股市:IMX Resources (ASX:IXR)已向中國發運第一批鐵銅礦石貨物;澳洲藥品開發公司Phylogica Limited (ASX:PYC)已與輝瑞製藥(NYSE:PFE)簽訂合作與許可證協議;Copper Strike Limited (ASX:CSE)在昆士蘭西北部的Walford Creek項目已取得良好的銅/銀/鈷結果;South American Ferro Metals Limited (ASX:SFZ)在巴西生產的鐵礦石超出400,000噸。
###
87,248 公司背景瀏覽
- 本頁瀏覽人次: (過去7日: 30) (過去30日: 112) (自發布以來: 9615)